Micro Interventional Devices is developing disruptive technologies that are revolutionizing percutaneous and minimally invasive structural heart repair procedures. Our proprietary technology is based on a breakthrough in soft- tissue anchoring and associated delivery devices that enable off-pump procedures.
Permaseal™ is a novel transapical access and closure device that combines soft -tissue anchors with advanced biocompatible elastomers to provide spontaneous wound closure after structural heart repair procedures, such as transcatheter aortic valve replacement (TAVR).
We acquired Endovalve, Inc. in April 2011. Our proprietary soft-tissue anchoring technology is being incorporated into the fully collapsible Endovalve design. The enhanced product will conform to the anatomy of the mitral annulus and provide for a leak-proof valve replacement with no risk of left ventricular outflow tract (aortic) obstruction.
Permaseal and Endovalve™ will drive the revolution in access and closure and mitral valve replacement, respectively.
Please click on the “Products” Tab for more information.
CAUTION: Exclusively for Clinical Investigations. These devices are not sold or offered for sale in the U.S.